These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38601756)

  • 1. The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study.
    Barclay NL; Pineda Moncusí M; Jödicke AM; Prieto-Alhambra D; Raventós B; Newby D; Delmestri A; Man WY; Chen X; Català M
    Front Oncol; 2024; 14():1370862. PubMed ID: 38601756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study.
    Barclay NL; Català M; Jödicke AM; Prieto-Alhambra D; Newby D; Delmestri A; Man WY; Serrano ÀR; Moncusí MP;
    Ther Adv Med Oncol; 2024; 16():17588359241253115. PubMed ID: 38832300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort Analysis.
    Barclay NL; Burkard T; Burn E; Delmestri A; Miquel Dominguez A; Golozar A; Guarner-Argente C; Avilés-Jurado FX; Man WY; Roselló Serrano À; Rosen AW; Tan EH; Tietzova I; Prieto Alhambra D; Newby D;
    Clin Epidemiol; 2024; 16():417-429. PubMed ID: 38882578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.
    Sud A; Torr B; Jones ME; Broggio J; Scott S; Loveday C; Garrett A; Gronthoud F; Nicol DL; Jhanji S; Boyce SA; Williams M; Riboli E; Muller DC; Kipps E; Larkin J; Navani N; Swanton C; Lyratzopoulos G; McFerran E; Lawler M; Houlston R; Turnbull C
    Lancet Oncol; 2020 Aug; 21(8):1035-1044. PubMed ID: 32702311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study.
    Maringe C; Spicer J; Morris M; Purushotham A; Nolte E; Sullivan R; Rachet B; Aggarwal A
    Lancet Oncol; 2020 Aug; 21(8):1023-1034. PubMed ID: 32702310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study.
    Carr MJ; Steeg S; Webb RT; Kapur N; Chew-Graham CA; Abel KM; Hope H; Pierce M; Ashcroft DM
    Lancet Public Health; 2021 Feb; 6(2):e124-e135. PubMed ID: 33444560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of the first UK lockdown for the COVID-19 pandemic on primary-care-recorded cancer and type-2 diabetes mellitus records: A population-based quasi-experimental time series study.
    Price S; Bailey S; Hamilton W; Jones D; Mounce L; Abel G
    Cancer Epidemiol; 2024 Aug; 91():102605. PubMed ID: 38959588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19·67 million people and evaluation of model performance against seven other risk prediction models.
    Liao W; Coupland CAC; Burchardt J; Baldwin DR; ; Gleeson FV; Hippisley-Cox J
    Lancet Respir Med; 2023 Aug; 11(8):685-697. PubMed ID: 37030308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Undiagnosed Cancer Cases in the US During the First 10 Months of the COVID-19 Pandemic.
    Burus T; Lei F; Huang B; Christian WJ; Hull PC; Ellis AR; Slavova S; Tucker TC; Lang Kuhs KA
    JAMA Oncol; 2024 Apr; 10(4):500-507. PubMed ID: 38386344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noteworthy impacts of COVID-19 pandemic on cancer screening: A systematic review.
    Wang H; Yang M; Xiong W; Wang Q; Zheng B; Bai Y; Zou K; Li J; Ren J; Chen W; Zhai J; Li J
    Fundam Res; 2024 May; 4(3):484-494. PubMed ID: 38933198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the COVID-19 pandemic on eating disorders diagnoses among adolescents and young adults in Catalonia: A population-based cohort study.
    Raventós B; Abellan A; Pistillo A; Reyes C; Burn E; Duarte-Salles T
    Int J Eat Disord; 2023 Jan; 56(1):225-234. PubMed ID: 36352763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the SARS-CoV-2 pandemic on female breast, colorectal and non-small cell lung cancer incidence, stage and healthcare pathway to diagnosis during 2020 in Wales, UK, using a national cancer clinical record system.
    Greene G; Griffiths R; Han J; Akbari A; Jones M; Lyons J; Lyons RA; Rolles M; Torabi F; Warlow J; Morris ERA; Lawler M; Huws DW
    Br J Cancer; 2022 Aug; 127(3):558-568. PubMed ID: 35501391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19 control on lung, breast, and colorectal pathological cancer diagnoses. A comparison between the Netherlands, Aotearoa New Zealand, and Northern Ireland.
    Mitchell H; Mclean J; Gavin AT; Visser O; Millar E; Luff T; Bennett D
    BMC Cancer; 2023 Jul; 23(1):700. PubMed ID: 37495980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study.
    Mansfield KE; Mathur R; Tazare J; Henderson AD; Mulick AR; Carreira H; Matthews AA; Bidulka P; Gayle A; Forbes H; Cook S; Wong AYS; Strongman H; Wing K; Warren-Gash C; Cadogan SL; Smeeth L; Hayes JF; Quint JK; McKee M; Langan SM
    Lancet Digit Health; 2021 Apr; 3(4):e217-e230. PubMed ID: 33612430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in Argentina.
    Pereyra L; Steinberg L; Lasa J; Marconi A; Calderwood AH; Pellisé M
    Gastroenterol Hepatol; 2024 Feb; 47(2):140-148. PubMed ID: 36934841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of warfarin therapy on breast, colorectal, lung, and prostate cancer survival: a population-based cohort study using the Clinical Practice Research Datalink.
    O'Rorke MA; Murray LJ; Hughes CM; Cantwell MM; Cardwell CR
    Cancer Causes Control; 2015 Mar; 26(3):355-66. PubMed ID: 25534917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19-related health care disruptions on pathologic cancer staging during the first pandemic year: a retrospective cohort study from March 2018 to March 2021.
    Tran C; Cipriano LE; Driman DK
    CMAJ Open; 2023; 11(3):E475-E484. PubMed ID: 37279981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the COVID-19 pandemic on breast, colorectal, lung, and prostate cancer stage at diagnosis according to race.
    Berrian J; Liu Y; Ezenwajiaku N; Moreno-Aspitia A; Holton SJ; Toriola AT; Colditz GA; Housten AJ; Hall L; Fiala MA; Ademuyiwa FO
    Cancer Med; 2023 Mar; 12(6):7381-7388. PubMed ID: 36404491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.